DBV Technologies S.A.
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and
Total Number of Shares of the Company as of December 31, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 12/31/2025 | 232,207,589 | Total gross of voting rights: 232,207,589 |
| Total net* of voting rights: 232,133,009 |
* Net total = total number of voting rights attached to shares – shares without voting rights
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Modelo7.1.2026 15:00:00 CET | Press release
Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option
Genmab A/S7.1.2026 15:00:00 CET | Press release
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
CNH Industrial N.V.7.1.2026 15:00:00 CET | Press release
AE50 2026: ASABE lists three Ag Tech innovations from CNH
BTCS, Inc.7.1.2026 14:30:00 CET | Press release
BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter
Egle Therapeutics7.1.2026 14:00:00 CET | Press release
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom